Показано 0 из 0
Дата |
---|
26.09.2023 |
25.09.2023 |
22.09.2023 |
21.09.2023 |
20.09.2023 |
19.09.2023 |
18.09.2023 |
15.09.2023 |
14.09.2023 |
13.09.2023 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
1.23
|
1.34
|
1.80
|
1.80
|
1.80
|
1.80
|
|
|
|
|
1.71
|
1.88
|
1.74
|
1.74
|
1.74
|
1.74
|
|
|
|
|
1.75
|
1.90
|
1.68
|
1.68
|
1.68
|
1.68
|
|
|
|
|
1.63
|
1.79
|
1.52
|
1.52
|
1.52
|
1.52
|
|
|
|
|
1.54
|
1.69
|
1.56
|
1.56
|
1.56
|
1.56
|
|
|
|
|
1.61
|
1.75
|
1.63
|
1.63
|
1.63
|
1.63
|
|
|
|
|
1.66
|
1.81
|
1.76
|
1.76
|
1.76
|
1.76
|
|
|
|
|
1.80
|
1.96
|
1.88
|
1.88
|
1.88
|
1.88
|
|
|
|
|
1.91
|
2.10
|
1.98
|
1.98
|
1.98
|
1.98
|
|
|
|
|
1.90
|
2.04
|
1.96
|
1.96
|
1.96
|
1.96
|
|
|
|
|
Fresh2 Group Limited operates as a biotechnology company focusing on early cancer screening and detection. The Company markets and sells a multi-cancer screening and detection test through its cancer differentiation analysis technology and devices. Fresh2 Group operates clinical laboratories in China and the United States.